Improving drug use: a case study of events which led to changes in use of flucloxacillin in Australia (Q57305050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Improving drug use: a case study of events which led to changes in use of flucloxacillin in Australia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

Elizabeth E. Roughead

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

A L Gilbert

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J G Primrose

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

Social Science and Medicine

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

845-853

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

Cholestatic hepatitis associated with flucloxacillin

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

Development of an Australian drug utilisation database: a report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

Risk factors for development of flucloxacillin associated jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

CDC's Planned Approach to Community Health as an Application of PRECEED and an Inspiration for PROCEED

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

Clinical practice guidelines in general practice: a national survey of recall, attitudes and impact.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

Stages of change and decisional balance for 12 problem behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

Improving drug prescribing in primary care: a critical analysis of the experimental literature

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

A framework for health promotion and disease prevention programs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2898%2900405-5

7 January 2021

10.1016/S0277-9536(98)00405-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190645%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference